|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Aug 25 | Sale | 1.15 | 27,000 | 31,050 | 668,840 | May 09 05:27 PM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Feb 29 | Sale | 1.58 | 7,169 | 11,327 | 695,840 | Mar 01 05:46 PM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Feb 27 | Sale | 1.52 | 8,367 | 12,718 | 703,009 | Feb 29 06:01 PM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Feb 01 | Sale | 1.68 | 24,311 | 40,842 | 711,376 | Feb 02 04:10 PM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | May 16 | Sale | 1.07 | 63,567 | 67,890 | 530,487 | May 18 06:20 PM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Mar 01 | Sale | 0.88 | 14,123 | 12,393 | 594,054 | Mar 03 08:01 AM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Feb 27 | Sale | 0.81 | 7,539 | 6,131 | 608,177 | Mar 01 04:06 PM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Aug 31 | Sale | 0.36 | 1,147 | 416 | 418,016 | Sep 01 04:15 PM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Feb 28 | Sale | 2.15 | 7,400 | 15,946 | 163,819 | Mar 02 09:12 PM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Mar 01 | Sale | 2.17 | 7,656 | 16,619 | 217,263 | Mar 02 09:12 PM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Aug 31 | Sale | 2.83 | 1,042 | 2,949 | 171,219 | Sep 02 04:07 PM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Mar 01 | Sale | 3.40 | 7,558 | 25,668 | 161,442 | Mar 02 04:06 PM |
AKBA | Burke Steven Keith | SVP, Chief Medical Officer | Nov 20 | Buy | 3.58 | 27,000 | 96,660 | 37,000 | Nov 22 06:19 AM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite